Concurrent Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
23,781
+1,471
+7% +$65.7K 0.01% 1002
2026
Q1
$1.07M Buy
22,310
+1,902
+9% +$88.7K 0.01% 846
2025
Q4
$989K Buy
20,408
+7,774
+62% +$385K 0.01% 837
2025
Q3
$596K Buy
12,634
+408
+3% +$19.7K 0.01% 841
2025
Q2
$591K Buy
12,226
+2,526
+26% +$129K 0.01% 787
2025
Q1
$538K Sell
9,700
-28,246
-74% -$1.53M 0.01% 731
2024
Q4
$1.83M Buy
37,946
+973
+3% +$49.5K 0.05% 343
2024
Q3
$2.13M Buy
36,973
+1,883
+5% +$102K 0.06% 301
2024
Q2
$1.7M Buy
+35,090
New +$1.69M 0.06% 314

Other funds holding SNY

Concurrent Investment Advisors's SNY Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Sanofi (SNY) stake by 6.6% in Q2 2026, buying an estimated $65.7K and bringing the position to 23,781 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #1002.

Concurrent Investment Advisors first reported a position in SNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.13M in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Concurrent Investment Advisors held 23,781 shares of Sanofi worth $1.01M as of Q2 2026.
  • Concurrent Investment Advisors bought 1,471 Sanofi shares in Q2 2026, an estimated $65.7K.
  • Sanofi made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1002 holding.
  • Concurrent Investment Advisors first reported a position in Sanofi in Q2 2024 and has held it in 9 quarters since.
  • Concurrent Investment Advisors's Sanofi position peaked at $2.13M in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.